Dysfunctional transforming growth factor‐β signaling with constitutively active notch signaling in Barrett's esophageal adenocarcinoma

Abstract

Our findings demonstrated a potential therapeutic value for targeted therapy in esophageal adenocarcinoma in the setting of loss of β2SP/TGF-β with concomitant constitutively active Notch signaling.